Breaking Down H&K AG Financial Health: Key Insights for Investors

Curious whether H&K AG's balance sheet and income statement back up its market buzz? In the first half of 2025 the company posted net sales of €179.5 million (up 4.7% YoY) and Q3 net sales jumped to €99.6 million - a striking 21% year‑over‑year gain - helping drive a trailing twelve‑month revenue of €349.98 million with revenue per share of €9.77 and quarterly revenue growth of 8.80%; gross profit TTM stands at €119.08 million with a 34.0% gross margin and an operating margin of 13.24%, while profitability metrics show TTM net profit margin at 8.65%, EBITDA €66.39 million (19.0% margin), EPS €0.85 and high capital efficiency with ROE 28.28% and ROIC 15.23% even as H1 net income slipped to €11.8 million from €12.9 million a year earlier; the balance sheet lists total assets of €444 million, liabilities €300.4 million and equity €143.6 million (debt‑to‑equity 0.59) with net working capital €129.9 million, current ratio 1.70 and quick ratio 0.57, while liquidity shows cash and short‑term investments of €27.2 million (a 51.96% increase YoY), quarterly operating cash flow rebounded to €37.8 million from -€9.6 million, capex was €4.0 million and free cash flow remained negative; valuation places market cap at €1.60 billion (EV €1.64 billion) with a trailing P/E of 65.5 (down from 149 in 2024), EV/EBITDA 26.78, P/S 4.35, P/B 10.36 and an estimated intrinsic value of €24.65 implying the stock may be ~45.20% overvalued, while material risk factors-strict export controls, competition from FN Herstal/Sig Sauer/Beretta, dependence on government contracts, supply‑chain constraints and geopolitical headwinds-sit alongside growth avenues in emerging markets, civilian product expansion, continued R&D and capacity investments that could reshape H&K's revenue mix and investor thesis.

H&K AG (MLHK.PA) - Revenue Analysis

• Net sales H1 2025: €179.5 million (up 4.7% from €171.4 million in H1 2024).
• Q3 2025 net sales: €99.6 million (up 21% vs. €82.3 million in Q3 2024).
• TTM revenue: €349.98 million with quarterly revenue growth of 8.80%.
• Revenue per share (TTM): €9.77.

• Gross profit (TTM): €119.08 million - gross margin: 34.0%.
• Operating margin (TTM): 13.24%.
• Return on Assets (ROA): 8.48%.
• Quarterly earnings growth (YoY): 137.50% (TTM basis noted).

H&K AG (MLHK.PA) - Profitability Metrics

H&K AG's recent profitability profile shows solid operating performance paired with mixed bottom-line trends through the trailing twelve months (TTM) and the first half of 2025. Key ratios indicate efficient capital use and healthy operating margins, though headline net income dipped in H1 2025 versus H1 2024.

• Net income (H1 2025): €11.8 million (down from €12.9 million in H1 2024)
• TTM net profit margin: 8.65%
• TTM operating margin: 13.24%
• TTM EBITDA: €66.39 million; EBITDA margin: 19.0%
• Return on equity (ROE): 28.28%
• Return on invested capital (ROIC): 15.23%
• TTM earnings per share (EPS): €0.85; quarterly earnings growth YoY: 137.50%
• TTM effective tax rate: 18.61%

For context on the company's broader strategy and background that supports these metrics, see: H&K AG: History, Ownership, Mission, How It Works & Makes Money

• High ROE (28.28%) suggests strong shareholder returns relative to equity; ROIC at 15.23% indicates efficient allocation of invested capital versus cost of capital.
• EBITDA margin of 19.0% and operating margin of 13.24% reflect robust core profitability before and after operating expenses.
• Despite strong margin metrics and EPS growth, the drop in H1 net income underscores near-term volatility or one-off items affecting the bottom line.

H&K AG (MLHK.PA) - Debt vs. Equity Structure

• Total assets: €444.0 million
• Total liabilities: €300.4 million
• Total equity: €143.6 million
• Net working capital: €129.9 million

• Leverage context: With liabilities of €300.4M against equity of €143.6M, the capital structure is equity-supportive while still employing debt to finance growth and operations.
• Liquidity nuance: Current ratio 1.70 signals working-capital sufficiency, but quick ratio 0.57 highlights reliance on inventory turnover to meet near-term obligations.
• Profitability & coverage: Interest coverage at 10.97x reduces refinancing and default risk, giving management flexibility on debt timing.
• Operational buffer: Net working capital of €129.9M provides a notable cushion for day-to-day operations and seasonal demand swings.

H&K AG (MLHK.PA) - Liquidity and Solvency

Key liquidity and solvency metrics for H&K AG (MLHK.PA) as of June 2025 highlight strengthened cash reserves, reduced short-term leverage, and active investment in capacity - offset by reported negative free cash flow and an 18.61% TTM effective tax rate that affects net cash retention.

• Cash & short-term investments: €27.2 million (up 51.96% year-over-year)
• Net overdraft utilization: €0 (no reliance on overdraft/short-term borrowing)
• Operational cash flow (quarter): €37.8 million (prior quarter: -€9.6 million)
• Capital expenditures (quarter): €4.0 million
• Free cash flow: Negative (capital expenditures and other outflows exceeded operating cash inflows)
• Effective tax rate (TTM): 18.61%

• Liquidity posture: improved cash buffer with €27.2m on hand and no overdraft suggests short-term resilience.
• Cash generation trend: sharp QoQ improvement in operating cash flow from -€9.6m to €37.8m indicates operational recovery, but reported negative free cash flow signals capital and/or financing outflows absorbing cash.
• Capex profile: €4.0m this quarter demonstrates continued capex discipline and capacity investment; monitor cadence vs. operating cash to assess sustainability.
• Tax impact: 18.61% effective rate will reduce net income-to-cash conversion and should be included in cash-flow forecasting.

For broader context on corporate history and business model, see: H&K AG: History, Ownership, Mission, How It Works & Makes Money

H&K AG (MLHK.PA) Valuation Analysis

Key market and valuation metrics for H&K AG as of December 2025 highlight a stock trading at a meaningful premium across multiple measures, despite some improvement in earnings-driven ratios year-over-year.

• Market capitalization: €1.60 billion
• Enterprise value (EV): €1.64 billion
• Trailing P/E: 65.5 (down from 149 in 2024)
• EV/EBITDA: 26.78
• EV/EBITDA (alternate reported): 52.97
• Price-to-Sales (P/S): 4.35
• Price-to-Book (P/B): 10.36
• EV/Revenue: 10.02
• Estimated intrinsic value per share: €24.65 (implying ~45.20% overvaluation vs. market price)

Numerical snapshot:

Investor takeaway (valuation-focused):

• High P/E and elevated EV multiples indicate the market prices H&K AG for strong growth or superior margins; trailing P/E improvement suggests earnings recovery relative to price.
• P/B of 10.36 and P/S of 4.35 reflect a substantial premium to balance-sheet and revenue bases - investors are paying for intangible value or future earnings potential.
• Discrepancy between EV/EBITDA 26.78 and 52.97 underscores the need to verify EBITDA definitions (trailing vs. adjusted/annualized) when comparing to peers.
• An intrinsic value estimate of €24.65 suggests significant upside to valuation assumptions or downside to the current price; this margin (~45.20%) frames potential downside risk if growth fails to materialize.

For strategic context and corporate priorities that may justify premium multiples, see Mission Statement, Vision, & Core Values (2026) of H&K AG.

H&K AG (MLHK.PA) - Risk Factors

H&K AG operates in a sector where regulatory, geopolitical and procurement dynamics materially influence financial outcomes. Below are the primary risks investors should monitor, with quantified indicators where available.

• Regulatory and export-control risk: H&K AG is subject to stringent export controls (ITAR-like frameworks and EU Common Position on arms exports). Historically, export approvals have delayed ~8-12% of international deliveries in peak years, and regulatory compliance costs account for an estimated €18-25 million annually (≈1.2-1.8% of recent revenues).
• Concentration of revenue via government contracts: Approximately 65-75% of H&K AG's annual revenue is derived from government and defense procurement (varies year-to-year). This concentration exposes cash flows to cyclical defence budgets and procurement timing.
• Competitive pressure: Major competitors include FN Herstal, Sig Sauer and Beretta. Combined, these peers account for roughly 40-55% of the global small-arms market, exerting pricing pressure and influencing contract awards.
• Supply chain and materials risk: Dependence on specialized materials (heat-treated steels, advanced polymers, electronics) creates vulnerability-supplier consolidation has extended average lead times from 6 to 10 weeks in recent supply-shock periods. Cost inflation for key inputs has contributed ~+3-6 percentage points to COGS in stressed years.
• Geopolitical risk: Exports to volatile regions account for roughly 20-30% of international sales; flare-ups or sanctions can result in order suspensions or cancellations. Political risk insurance and mitigation add incremental operating costs (~€3-7M/year).
• Defense spending and export-policy shifts: A 5% cut in core customer defense budgets could reduce H&K AG's contract inflows by an estimated 6-9% year-over-year given current customer mix and backlog sensitivity.
• Procurement and payment delays: Typical government procurement cycles can delay cash conversion - days sales outstanding (DSO) has ranged 55-85 days for contract receivables, and major program payments can be deferred by 6-18 months in some jurisdictions.

• Mitigants and monitoring points investors should watch:
  • Percentage of revenue under multi-year contracts vs. single-year awards (higher multi-year = lower budget risk).
  • Trend in export-license approval rates and any new sanctions/embargoes affecting customers.
  • Supplier concentration metrics (top-5 suppliers' share of critical inputs).
  • Liquidity metrics-cash on hand, undrawn credit lines relative to >12 months of operating expenses.

For historical context and corporate background related to H&K AG (MLHK.PA), see: H&K AG: History, Ownership, Mission, How It Works & Makes Money

H&K AG (MLHK.PA) - Growth Opportunities

• Emerging markets: targeted expansion in APAC, Latin America and selected African states where modernization programs are underway; management guidance indicates distributor network expansion of ~15-20% year-over-year in these regions.
• Civilian market penetration: new product launches aimed at specialized sport, competition and high-end civilian segments to capture incremental share and diversify revenue.
• Product-led differentiation: leveraging R&D to convert military-grade technologies into premium civilian offerings (suppressors, precision optics-integrated platforms, modular rifles).

• Regulatory adaptability: streamlined compliance teams and modular product architectures reduce time-to-market in jurisdictions with changing firearms regulations.
• Aftermarket & services: training programs, spare parts and maintenance contracts provide annuity-like revenue; services growth outpacing equipment sales in recent quarters (~10-12% CAGR in services historically reported by peers).
• Production scale-up: ongoing investments in automation and supply-chain localization to shorten lead times and improve margin resiliency.